Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Intranasal Ketorolac in Children
NCT02297906Phase 1Terminated
- Sponsor
- Columbia University
- Start
- Feb 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ketorolac in pain (2 arms), sponsored by Columbia University. Primary endpoint: Maximum Serum Concentration at 60 minutes. Started Feb 2015; status: terminated.
02
Drugs
ketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT02297906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297906.